Great Western Mining has reported encouraging progress at its wholly owned Pine Crow-Defender tungsten prospect in Nevada, following the completion of a machine-cut channel sampling programme in December...
Take a look back at Ilika’s 2025 progress, as the company moved from laboratory validation to manufacturing, delivering key Stereax and Goliath solid-state battery milestones...
B HODL acquires 1 Bitcoin using £70,000 loan drawdown, increasing total holdings to 158.211 BTC as part of its ongoing treasury accumulation strategy...
Ecofin U.S. Renewables Infrastructure Trust has completed the sale of its Whirlwind asset to Buho Infrastructure, including escrow and contingent payments aligned with its investment policy...
Sintana Energy Inc. has announced the admission of its common shares to the AIM market of the London Stock Exchange, with trading commencing on 23 December 2025 under the ticker SEI...
Hardman & Co’s Mark Thomas explains why NB Private Equity Partners’ 2024 dip is masking a much stronger long-term growth story—one backed by impressive realisation multiples, stable EBITDA growth, and expanding investment opportunities...
CEO Bert Munro outlines how the company is optimising its Sanankoro Gold Project in South Mali with a redesigned processing plant that cuts power usage and capital intensity...
From a windswept ridge in South Australia’s Flinders Ranges, Managing Director Andrew Hume shares how Thor Energy Plc (LON:THR) is harnessing ancient geology to pioneer a low-cost, naturally occurring hydrogen and helium opportunity...
CEO Graeme Purdy outlines how the funds are being deployed, the momentum behind Ilika’s US manufacturing partnership, and why upcoming government grants could turbocharge their ambitions..
With competitive lending terms and flexibility around equity conversion, this deal positions CyanConnode to accelerate project delivery without shareholder dilution..
AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...
GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...
GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026...
Entain has confirmed that long-serving CFO and Deputy CEO Rob Wood will step down in 2026, with Michael Snape set to join as CFO Designate in February before taking the role in March...
Vistry Group expects adjusted profit before tax of around £270m for FY25, up from £263.5m in FY24, supported by strong second-half margin progression...
Raspberry Pi said it expects adjusted FY2025 EBITDA to exceed market expectations at not less than $45m, driven by strong H2 unit economics and resilient demand...
Oxford Nanopore Technologies expects to report full year 2025 revenue of approximately £223–£224 million, representing around 22% reported growth and 24% growth at constant currency, slightly ahead of guidance...
Ruffer Investment Company's portfolio was broadly flat in December, rounding out a strong fourth quarter and a calendar year that delivered double-digit returns net of fees...
